Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 364

1.

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.

Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D.

BMJ. 2004 Oct 23;329(7472):948. Epub 2004 Oct 8. Review.

2.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

3.

Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.

Jacobsen RB, Phillips BB.

Ann Pharmacother. 2004 Sep;38(9):1469-81. Epub 2004 Jun 22. Review.

PMID:
15213313
6.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

7.

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.

Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG; National Institute for Health and Clinical Excellence Osteoarthritis Guideline Development Group.

BMJ. 2009 Jul 14;339:b2538. doi: 10.1136/bmj.b2538.

8.

Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.

Naesdal J, Wilson I.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1401-6. Review.

PMID:
11742186
11.

Prevention of NSAID-induced gastroduodenal ulcers.

Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J.

Cochrane Database Syst Rev. 2002;(4):CD002296. Review.

PMID:
12519573
12.

Prevention of chronic NSAID induced upper gastrointestinal toxicity.

Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J.

Cochrane Database Syst Rev. 2000;(3):CD002296. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD002296.

PMID:
10908548
13.

Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.

Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.

J Rheumatol. 2002 Mar;29(3):467-73.

PMID:
11908558
14.

Prevention of NSAID-induced gastroduodenal ulcers.

Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J.

Cochrane Database Syst Rev. 2000;(4):CD002296. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD002296.

PMID:
11034748
15.

Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents.

You JH, Lee KK, Chan TY, Lau WH, Chan FK.

Aliment Pharmacol Ther. 2002 Dec;16(12):2089-96.

16.

Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.

Bertolini A, Ottani A, Sandrini M.

Curr Med Chem. 2002 May;9(10):1033-43. Review.

PMID:
12733982
17.

An evidence-based approach to the gastrointestinal safety profile of COX-2-selective anti-inflammatories.

Schoenfeld P.

Gastroenterol Clin North Am. 2001 Dec;30(4):1027-44, viii-ix. Review.

PMID:
11764531
18.

Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.

Yuan JQ, Tsoi KK, Yang M, Wang JY, Threapleton DE, Yang ZY, Zou B, Mao C, Tang JL, Chan FK.

Aliment Pharmacol Ther. 2016 Jun;43(12):1262-75. doi: 10.1111/apt.13642. Epub 2016 Apr 28. Review.

PMID:
27121479
20.

A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.

Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.

Rheumatology (Oxford). 2005 Jul;44(7):921-4. Epub 2005 Apr 12.

PMID:
15827035

Supplemental Content

Support Center